|
| Status |
Public on Mar 30, 2012 |
| Title |
wildtype macrophages treated with control peptide, technical replicate 3 |
| Sample type |
RNA |
| |
|
| Source name |
primary bone marrow derived macrophages
|
| Organism |
Mus musculus |
| Characteristics |
strain: c57Bl6/J
age: 10 week old males
tissue: macrophages
|
| Extracted molecule |
total RNA |
| Extraction protocol |
RNA was extracted with Trizol reagent, followed by clean-up and DNase I treatment with QIAGEN RNeasy mini kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
|
| Label |
biotin
|
| Label protocol |
Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays
|
| |
|
| Hybridization protocol |
Standard Illumina hybridization protocol
|
| Scan protocol |
Standard Illumina scanning protocol
|
| Description |
technical replicate 3
|
| Data processing |
The data were normalized using cubic spline in Illumina GenomeStudio and also using the VAMPIRE Bayesian model with a 2-sided Bonferroni-corrected threshold of 0.05.
|
| |
|
| Submission date |
Feb 01, 2011 |
| Last update date |
Mar 30, 2012 |
| Contact name |
Ruth T Yu |
| Organization name |
Salk Institute
|
| Department |
Gene Expression Lab
|
| Lab |
Ronald Evans
|
| Street address |
10010 N Torrey Pines Rd
|
| City |
La Jolla |
| State/province |
CA |
| ZIP/Postal code |
92037 |
| Country |
USA |
| |
|
| Platform ID |
GPL6887 |
| Series (2) |
| GSE27001 |
Inhibition of Bcl6-SMRT/NCoR interactions by an inhibitory peptide affects inflammatory pathways |
| GSE27060 |
A Bcl6-Smrt/Ncor repression program controls atherosclerosis |
|
